![](https://tracker.live.rns-distribution.com/track.live-rns/5133766_75d1671758db0ed18eba2dbba83793b2.png)
London, 8 April 2024
Georgia Capital PLC announces change of registered office
Georgia Capital PLC (the "Company") announces that it has changed it registered office, with effect from 8 April 2024 to:
Central Square
29 Wellington Street
Leeds
LS1 4DL
Name of authorised official of issuer responsible for making notification: Shalva Bukia, Head of Investor Relations and Funding
About Georgia Capital PLC
Georgia Capital (LEI: 213800Q65T5GNBOW7H65) is a platform for buying, building and developing businesses in Georgia with holdings in sectors that are expected to benefit from the continued growth and further diversification of the Georgian economy. The Company's focus is typically on larger-scale investment opportunities in Georgia, which have the potential to reach at least GEL 300 million equity value over 3-5 years from the initial investment and to monetise them through exits, as investments mature. Georgia Capital currently has the following portfolio businesses: (i) a retail (pharmacy) business, (ii) a hospitals business, (iii) an insurance business (P&C and medical insurance); (iv) a renewable energy business (hydro and wind assets), (v) an education business and (vi) a clinics and diagnostics business; Georgia Capital also holds other small private businesses across different industries in Georgia; a 20.0% equity stake in the water utility business and a 19.71% equity stake (at 31-Dec-23) in LSE premium-listed Bank of Georgia Group PLC ("BoG"), a leading universal bank in Georgia.
JSC Georgia Capital has, as of the date hereof, the following credit rating: | |
| |
S&P Global | 'BB-'/FC & 'BB-'/LC |
For further information, please visit www.georgiacapital.ge or contact:
Irakli Gilauri | Giorgi Alpaidze | Michael Oliver | Shalva Bukia |
Chairman and Chief Executive | Chief Financial Officer | Adviser to the Chairman & CEO | Head of Investor Relations |
+995 322 005 000 | +44 203 178 4034 | + 995 322 005 045 | |
|
This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.